T1	Participant 45 58	mouth cancers
T2	Participant 132 145	mouth cancers
T3	Intervention 285 297	chemotherapy
T4	Intervention 312 391	methotrexate 400 mg followed by citrovorum factor 100 mg + bleomycin 60 mg/week
T10	Intervention 459 505	immunotherapy with weekly C. parvum injections
T12	Intervention 565 578	any treatment
T13	Observation 640 662	significantly decrease
T14	Outcome 667 682	recurrence rate
T17	Outcome 685 693	Survival
T18	Observation 706 728	signigicantly modified
T19	Observation 759 765	better
T20	Participant 784 796	small tumors
T21	Intervention 732 750	adjuvant treatment
T22	Participant 832 844	radiotherapy
T23	Observation 853 860	benefit
T24	Intervention 866 882	adjuvant therapy
T25	Intervention 0 17	Adjvant treatment
T15	Intervention 584 602	adjuvant treatment
T11	Outcome 618 628	recurrence
T16	Observation 612 617	delay
R1	to Arg1:T15 Arg2:T16	
R2	to Arg1:T16 Arg2:T11	
R3	to Arg1:T15 Arg2:T13	
R4	to Arg1:T13 Arg2:T14	
R5	to Arg1:T21 Arg2:T18	
R6	to Arg1:T18 Arg2:T17	
R7	to Arg1:T21 Arg2:T19	
R8	to Arg1:T24 Arg2:T23	
